Clear Perspective Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$498K Sell
5,693
-109
-2% -$9.05K 0.15% 101
2021
Q3
$474K Sell
5,802
-290
-5% -$26.1K 0.16% 92
2021
Q2
$556K Sell
6,092
-238
-4% -$21.2K 0.19% 81
2021
Q1
$541K Sell
6,330
-487
-7% -$43.7K 0.21% 80
2020
Q4
$644K Sell
6,817
-312
-4% -$27.3K 0.26% 70
2020
Q3
$513 Sell
7,129
-122
-2% -$10.6K 0.24% 76
2020
Q2
$633K Sell
7,251
-531
-7% -$45.8K 0.35% 52
2020
Q1
$642K Sell
7,782
-720
-8% -$64.2K 0.43% 46
2019
Q4
$805K Sell
8,502
-200
-2% -$17.9K 0.5% 50
2019
Q3
$756K Buy
8,702
+220
+3% +$19.8K 0.34% 66
2019
Q2
$774K Sell
8,482
-1,281
-13% -$108K 0.5% 50
2019
Q1
$701K Sell
9,763
-279
-3% -$22.4K 0.5% 53
2018
Q4
$772K Buy
10,042
+223
+2% +$17.4K 0.64% 41
2018
Q3
$758K Sell
9,819
-205
-2% -$15.2K 0.56% 51
2018
Q2
$679K Sell
10,024
-184
-2% -$12.7K 0.47% 57
2018
Q1
$740K Sell
10,208
-1,518
-13% -$116K 0.55% 45
2017
Q4
$882K Sell
11,726
-317
-3% -$23.9K 0.67% 34
2017
Q3
$926K Sell
12,043
-206
-2% -$15.6K 0.76% 33
2017
Q2
$916K Sell
12,249
-391
-3% -$27.7K 0.77% 38
2017
Q1
$841K Sell
12,640
-10
-0.1% -$666 0.56% 46
2016
Q4
$826K Buy
+12,650
New +$821K 0.55% 41

Other funds holding NVS

Clear Perspective Advisors's NVS Position: Q4 2021 in Review

Clear Perspective Advisors reduced its Novartis (NVS) stake by 1.9% in Q4 2021, selling an estimated $9.05K and leaving 5,693 shares worth $498K. The position accounts for 0.15% of the portfolio, ranked #101.

Clear Perspective Advisors first reported a position in NVS in Q4 2016 and has held it in 21 quarters since. The position peaked at $926K in Q3 2017. 1,147 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

  • Clear Perspective Advisors held 5,693 shares of Novartis worth $498K as of Q4 2021.
  • Clear Perspective Advisors sold 109 Novartis shares in Q4 2021, an estimated $9.05K.
  • Novartis made up 0.15% of Clear Perspective Advisors's portfolio in Q4 2021, its #101 holding.
  • Clear Perspective Advisors first reported a position in Novartis in Q4 2016 and has held it in 21 quarters since.
  • Clear Perspective Advisors's Novartis position peaked at $926K in Q3 2017.
  • 1,147 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Clear Perspective Advisors's 13F filing for Q4 2021, filed 17 Feb 2022.